000 01614 a2200457 4500
005 20250515191139.0
264 0 _c20091016
008 200910s 0 0 eng d
022 _a1533-4406
024 7 _a10.1056/NEJMoa0810925
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRiches, Philip L
245 0 0 _aOsteoporosis associated with neutralizing autoantibodies against osteoprotegerin.
_h[electronic resource]
260 _bThe New England journal of medicine
_cOct 2009
300 _a1459-65 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAutoantibodies
_xblood
650 0 4 _aAutoimmune Diseases
650 0 4 _aBiomarkers
_xblood
650 0 4 _aBone Density
_ximmunology
650 0 4 _aBone Remodeling
650 0 4 _aCeliac Disease
_xcomplications
650 0 4 _aDiet, Gluten-Free
650 0 4 _aHumans
650 0 4 _aHypothyroidism
_xcomplications
650 0 4 _aImmunoglobulin A
_xblood
650 0 4 _aMale
650 0 4 _aOsteoporosis
_xdrug therapy
650 0 4 _aOsteoprotegerin
_ximmunology
650 0 4 _aRANK Ligand
_xmetabolism
650 0 4 _aReceptor Activator of Nuclear Factor-kappa B
_xmetabolism
650 0 4 _aTransglutaminases
_ximmunology
700 1 _aMcRorie, Euan
700 1 _aFraser, William D
700 1 _aDetermann, Catherine
700 1 _avan't Hof, Rob
700 1 _aRalston, Stuart H
773 0 _tThe New England journal of medicine
_gvol. 361
_gno. 15
_gp. 1459-65
856 4 0 _uhttps://doi.org/10.1056/NEJMoa0810925
_zAvailable from publisher's website
999 _c19207195
_d19207195